营销话术反驳的证据:低(机制说得通,人体试验少)
萝卜硫素补剂等于一大筐西兰花
证据怎么说
只含萝卜硫苷的要靠肠道细菌,转化从 1% 到 40% 以上不等;疗效试验小,结果不一。
这话术为什么会流行
萝卜硫素在细胞和动物里的机制确实很漂亮,补剂又省掉了切、等、轻蒸这些麻烦。听起来像是把一筐西兰花压成了一粒。
机制速览
萝卜硫素补剂卖的,其实是西兰花里那条转化路上的某一步。买之前看清是哪一步,因为它决定你最后能得到多少萝卜硫素。
来源(6)
- Fahey, J. W., Wehage, S. L., Holtzclaw, W. D., Kensler, T. W., Egner, P. A., Shapiro, T. A., & Talalay, P. (2012). Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prevention Research, 5(4), 603-611.
- Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., et al. (2011). Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prevention Research, 4(3), 384-395.
- Fahey, J. W., Holtzclaw, W. D., Wehage, S. L., Wade, K. L., Stephenson, K. K., & Talalay, P. (2015). Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase. PLoS ONE, 10(11), e0140963.
- Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proceedings of the National Academy of Sciences of the United States of America, 111(43), 15550-15555.
- Zimmerman, A. W., Singh, K., Connors, S. L., Liu, H., Panjwani, A. A., Lee, L. C., et al. (2021). Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Molecular Autism, 12(1), 38.
- Ou, J., Smith, R. C., Tobe, R. H., Lin, J., Arriaza, J., Fahey, J. W., et al. (2024). Efficacy of sulforaphane in treatment of children with autism spectrum disorder: a randomized double-blind placebo-controlled multi-center trial. Journal of Autism and Developmental Disorders, 54(2), 628-641.